Wendt India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 12, 2025, 1:35 pm

Quick Insight

Wendt India Ltd, operating in the abrasives and grinding wheels sector, currently trades at a price of ₹10,048 with a market capitalization of ₹2,011 Cr. The company's P/E stands at 56.5, reflecting a premium valuation, while its ROE and ROCE are at 15.1% and 19.8%, respectively, indicating healthy returns. With an OPM of 13.95% and a solid ICR of 1227.00x, Wendt shows operational efficiency and strong debt repayment capacity. However, the high P/BV ratio of 7.32x suggests an expensive stock relative to its book value. Investors should consider the company's strong financial position and profitability metrics but be cautious about the premium valuation.

Competitors of Wendt India Ltd

All Competitor Stocks of Wendt India Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:10 am

Below is a detailed analysis of the quarterly data for Wendt India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 52.17 Cr.. The value appears to be declining and may need further review. It has decreased from 75.60 Cr. (Mar 2025) to 52.17 Cr., marking a decrease of 23.43 Cr..
• For Expenses, as of Jun 2025, the value is 44.89 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 57.25 Cr. (Mar 2025) to 44.89 Cr., marking a decrease of 12.36 Cr..
• For Operating Profit, as of Jun 2025, the value is 7.28 Cr.. The value appears to be declining and may need further review. It has decreased from 18.35 Cr. (Mar 2025) to 7.28 Cr., marking a decrease of 11.07 Cr..
• For OPM %, as of Jun 2025, the value is 13.95%. The value appears to be declining and may need further review. It has decreased from 24.27% (Mar 2025) to 13.95%, marking a decrease of 10.32%.
• For Other Income, as of Jun 2025, the value is 1.70 Cr.. The value appears to be declining and may need further review. It has decreased from 2.11 Cr. (Mar 2025) to 1.70 Cr., marking a decrease of 0.41 Cr..
• For Interest, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
• For Depreciation, as of Jun 2025, the value is 3.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.30 Cr. (Mar 2025) to 3.44 Cr., marking an increase of 0.14 Cr..
• For Profit before tax, as of Jun 2025, the value is 5.53 Cr.. The value appears to be declining and may need further review. It has decreased from 17.15 Cr. (Mar 2025) to 5.53 Cr., marking a decrease of 11.62 Cr..
• For Tax %, as of Jun 2025, the value is 31.65%. The value appears to be increasing, which may not be favorable. It has increased from 24.84% (Mar 2025) to 31.65%, marking an increase of 6.81%.
• For Net Profit, as of Jun 2025, the value is 3.78 Cr.. The value appears to be declining and may need further review. It has decreased from 12.89 Cr. (Mar 2025) to 3.78 Cr., marking a decrease of 9.11 Cr..
• For EPS in Rs, as of Jun 2025, the value is 18.90. The value appears to be declining and may need further review. It has decreased from 64.45 (Mar 2025) to 18.90, marking a decrease of 45.55.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:43 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:04 pm

Below is a detailed analysis of the balance sheet data for Wendt India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Reserves, as of Mar 2025, the value is 242.00 Cr.. The value appears strong and on an upward trend. It has increased from 210.00 Cr. (Mar 2024) to 242.00 Cr., marking an increase of 32.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 56.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 44.00 Cr. (Mar 2024) to 56.00 Cr., marking an increase of 12.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 301.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 256.00 Cr. (Mar 2024) to 301.00 Cr., marking an increase of 45.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 100.00 Cr.. The value appears strong and on an upward trend. It has increased from 58.00 Cr. (Mar 2024) to 100.00 Cr., marking an increase of 42.00 Cr..
• For CWIP, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 8.00 Cr..
• For Investments, as of Mar 2025, the value is 52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 73.00 Cr. (Mar 2024) to 52.00 Cr., marking a decrease of 21.00 Cr..
• For Other Assets, as of Mar 2025, the value is 139.00 Cr.. The value appears strong and on an upward trend. It has increased from 122.00 Cr. (Mar 2024) to 139.00 Cr., marking an increase of 17.00 Cr..
• For Total Assets, as of Mar 2025, the value is 301.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2024) to 301.00 Cr., marking an increase of 45.00 Cr..

Notably, the Reserves (242.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Wendt India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 197.43. This value is within the healthy range. It has decreased from 204.77 (Mar 24) to 197.43, marking a decrease of 7.34.
• For Diluted EPS (Rs.), as of Mar 25, the value is 197.43. This value is within the healthy range. It has decreased from 204.77 (Mar 24) to 197.43, marking a decrease of 7.34.
• For Cash EPS (Rs.), as of Mar 25, the value is 247.75. This value is within the healthy range. It has increased from 247.50 (Mar 24) to 247.75, marking an increase of 0.25.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,218.45. It has increased from 1,060.55 (Mar 24) to 1,218.45, marking an increase of 157.90.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,218.45. It has increased from 1,060.55 (Mar 24) to 1,218.45, marking an increase of 157.90.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,168.60. It has increased from 1,134.15 (Mar 24) to 1,168.60, marking an increase of 34.45.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 306.75. This value is within the healthy range. It has decreased from 313.80 (Mar 24) to 306.75, marking a decrease of 7.05.
• For PBIT / Share (Rs.), as of Mar 25, the value is 256.40. This value is within the healthy range. It has decreased from 271.05 (Mar 24) to 256.40, marking a decrease of 14.65.
• For PBT / Share (Rs.), as of Mar 25, the value is 256.15. This value is within the healthy range. It has decreased from 271.05 (Mar 24) to 256.15, marking a decrease of 14.90.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 197.40. This value is within the healthy range. It has decreased from 204.75 (Mar 24) to 197.40, marking a decrease of 7.35.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 197.40. This value is within the healthy range. It has decreased from 204.75 (Mar 24) to 197.40, marking a decrease of 7.35.
• For PBDIT Margin (%), as of Mar 25, the value is 26.24. This value is within the healthy range. It has decreased from 27.66 (Mar 24) to 26.24, marking a decrease of 1.42.
• For PBIT Margin (%), as of Mar 25, the value is 21.94. This value exceeds the healthy maximum of 20. It has decreased from 23.89 (Mar 24) to 21.94, marking a decrease of 1.95.
• For PBT Margin (%), as of Mar 25, the value is 21.91. This value is within the healthy range. It has decreased from 23.89 (Mar 24) to 21.91, marking a decrease of 1.98.
• For Net Profit Margin (%), as of Mar 25, the value is 16.89. This value exceeds the healthy maximum of 10. It has decreased from 18.05 (Mar 24) to 16.89, marking a decrease of 1.16.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.89. This value is within the healthy range. It has decreased from 18.05 (Mar 24) to 16.89, marking a decrease of 1.16.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.20. This value is within the healthy range. It has decreased from 19.30 (Mar 24) to 16.20, marking a decrease of 3.10.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.87. This value is within the healthy range. It has decreased from 25.37 (Mar 24) to 20.87, marking a decrease of 4.50.
• For Return On Assets (%), as of Mar 25, the value is 13.12. This value is within the healthy range. It has decreased from 16.01 (Mar 24) to 13.12, marking a decrease of 2.89.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. It has decreased from 0.93 (Mar 24) to 0.83, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 3.34. This value exceeds the healthy maximum of 3. It has decreased from 4.43 (Mar 24) to 3.34, marking a decrease of 1.09.
• For Quick Ratio (X), as of Mar 25, the value is 2.66. This value exceeds the healthy maximum of 2. It has decreased from 3.57 (Mar 24) to 2.66, marking a decrease of 0.91.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 4. It has decreased from 1.96 (Mar 24) to 1.89, marking a decrease of 0.07.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 14.65 (Mar 24) to 0.00, marking a decrease of 14.65.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 12.12 (Mar 24) to 0.00, marking a decrease of 12.12.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 85.35 (Mar 24) to 0.00, marking a decrease of 85.35.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 87.88 (Mar 24) to 0.00, marking a decrease of 87.88.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1,227.00. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 1,227.00, marking an increase of 1,227.00.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 790.60. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 790.60, marking an increase of 790.60.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,765.47. It has decreased from 2,252.14 (Mar 24) to 1,765.47, marking a decrease of 486.67.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.55. This value exceeds the healthy maximum of 3. It has decreased from 9.93 (Mar 24) to 7.55, marking a decrease of 2.38.
• For EV / EBITDA (X), as of Mar 25, the value is 28.78. This value exceeds the healthy maximum of 15. It has decreased from 35.88 (Mar 24) to 28.78, marking a decrease of 7.10.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.63. This value exceeds the healthy maximum of 3. It has decreased from 10.01 (Mar 24) to 7.63, marking a decrease of 2.38.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 85.34 (Mar 24) to 0.00, marking a decrease of 85.34.
• For Price / BV (X), as of Mar 25, the value is 7.32. This value exceeds the healthy maximum of 3. It has decreased from 10.70 (Mar 24) to 7.32, marking a decrease of 3.38.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.63. This value exceeds the healthy maximum of 3. It has decreased from 10.01 (Mar 24) to 7.63, marking a decrease of 2.38.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness